Cetraxal side effects by duration, gender and age - a phase IV clinical study of FDA data

< 1 month:

1. Asthenia (weakness)
2. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
3. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
4. Ear pain

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

1. Dysuria (painful or difficult urination)

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Diarrhoea
2. Fall
3. Drug hypersensitivity

female:

1. Diarrhoea
2. Fall
3. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
4. Ear pain

male:

1. Asthenia (weakness)
2. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
3. Drug hypersensitivity
4. Dysuria (painful or difficult urination)

0-1:

n/a

2-9:

n/a

10-19:

1. Dysuria (painful or difficult urination)
2. Ear pain

20-29:

n/a

30-39:

1. Diarrhoea
2. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)

40-49:

1. Asthenia (weakness)

50-59:

n/a

60+:

1. Fall
2. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
3. Drug hypersensitivity